Showing results (521-530 of 776) with videos related to
Sort By:
Pageof 78
Dermatology (Basel, Switzerland)|June 13, 2026
The Role of the Vagus Nerve and Its Stimulation in Modulating Inflammatory Skin Diseases and Other Dermatologic Conditions: From Mechanisms to TherapeuticsWilliam J Nahm, Vincent Falanga, Ki-Joong Kim, et al.Pediatric Dermatology|December 20, 2021
Review of the diagnosis and management of pediatric psychodermatologic conditions: Part IMegan Mosca, Kari Martin, Edward Hadeler, et al.The Journal of Dermatological Treatment|April 30, 2020
Optimizing doxepin therapy in dermatology: introducing blood level monitoring and genotype testingBridget Myers, Vidhatha Reddy, Stephanie Chan, et al.Journal of the American Academy of Dermatology|December 5, 2012
A prospective, interventional assessment of psoriasis quality of life using a nonskin-specific validated instrument that allows comparison with other major medical conditionsTina Bhutani, Tejas Patel, Bonnie Koo, et al.BMC Pulmonary Medicine|April 21, 2022
A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapiesAlyson W Wong, John Koo, Christopher J Ryerson, et al.Pediatric Dermatology|January 31, 2013
Clinical manifestations of pediatric psoriasis: results of a multicenter study in the United StatesKatherine Mercy, Mary Kwasny, Kelly M Cordoro, et al.Journal of Drugs in Dermatology : JDD|August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL StudyBruce Strober, Jerry Bagel, Mark Lebwohl, et al.Cureus|December 13, 2024
Accountability Frameworks in Medical Weight Loss Programs: A Comprehensive Literature ReviewOlivia C Silveri, Nicholas A Gallardo, Rithi J Chandy, et al.The Journal of Dermatological Treatment|October 21, 2016
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)Kristian Reich, Craig Leonardi, Mark Lebwohl, et al.Journal of Drugs in Dermatology : JDD|May 19, 2005
Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient creamDebra Breneman, Alan B Fleischer, David Kaplan, et al.Pageof 78